ID27544A - Agonis dan antagonis muskarinat - Google Patents

Agonis dan antagonis muskarinat

Info

Publication number
ID27544A
ID27544A IDW20010377A ID20010377A ID27544A ID 27544 A ID27544 A ID 27544A ID W20010377 A IDW20010377 A ID W20010377A ID 20010377 A ID20010377 A ID 20010377A ID 27544 A ID27544 A ID 27544A
Authority
ID
Indonesia
Prior art keywords
muscarinat
agonists
antagonists
muscarinat agonists
Prior art date
Application number
IDW20010377A
Other languages
English (en)
Inventor
Grewal Gurmit
Toy Palmer Anna
Cai Xiong
Latham George Mark
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of ID27544A publication Critical patent/ID27544A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IDW20010377A 1998-08-18 1999-08-16 Agonis dan antagonis muskarinat ID27544A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18

Publications (1)

Publication Number Publication Date
ID27544A true ID27544A (id) 2001-04-12

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010377A ID27544A (id) 1998-08-18 1999-08-16 Agonis dan antagonis muskarinat

Country Status (30)

Country Link
US (5) US6093724A (id)
EP (1) EP1112272B1 (id)
JP (1) JP2002523416A (id)
KR (1) KR20010072784A (id)
CN (1) CN1312812A (id)
AR (1) AR020199A1 (id)
AT (1) ATE227724T1 (id)
AU (1) AU750566B2 (id)
BG (1) BG105256A (id)
BR (1) BR9913072A (id)
CA (1) CA2340946A1 (id)
CO (1) CO5130018A1 (id)
DE (1) DE69903961T2 (id)
EE (1) EE200100096A (id)
ES (1) ES2191455T3 (id)
HK (1) HK1038918A1 (id)
HU (1) HUP0103203A3 (id)
ID (1) ID27544A (id)
IL (1) IL141050A0 (id)
IS (1) IS5827A (id)
NO (1) NO20010804L (id)
NZ (1) NZ509762A (id)
PE (1) PE20000988A1 (id)
PL (1) PL346247A1 (id)
RU (1) RU2219179C2 (id)
SK (1) SK1892001A3 (id)
TR (1) TR200100462T2 (id)
WO (1) WO2000011001A1 (id)
YU (1) YU13301A (id)
ZA (1) ZA200100978B (id)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031013A3 (en) * 2000-10-19 2004-03-17 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (en) * 2007-03-23 2012-09-12 Abbott Laboratories 4 -substituted azaadamantane derivatives and methods of use thereof
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2619205B1 (en) * 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3651762B1 (en) 2017-07-12 2024-07-03 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
JP7270989B2 (ja) 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
EP3732163A4 (en) * 2017-12-20 2021-07-14 Vanderbilt University MUSCARIN M4 ACETYLCHOLIN RECEPTOR ANTAGONISTS
PT3856182T (pt) 2018-09-28 2026-03-10 Karuna Therapeutics Inc Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
TR199800780T2 (xx) * 1995-11-02 1998-07-21 Neurosearch A/S Kayna�m�� tropan t�revleri, haz�rlan��lar� ve kullan�mlar�.
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
CO5130018A1 (es) 2002-02-27
BR9913072A (pt) 2001-05-15
TR200100462T2 (tr) 2001-09-21
US6323194B1 (en) 2001-11-27
US6251916B1 (en) 2001-06-26
HK1038918A1 (zh) 2002-04-04
ZA200100978B (en) 2002-02-05
PE20000988A1 (es) 2000-09-30
KR20010072784A (ko) 2001-07-31
EP1112272B1 (en) 2002-11-13
EE200100096A (et) 2002-06-17
ES2191455T3 (es) 2003-09-01
DE69903961T2 (de) 2003-07-03
WO2000011001A1 (en) 2000-03-02
US20020045617A1 (en) 2002-04-18
NZ509762A (en) 2002-12-20
SK1892001A3 (en) 2001-11-06
DE69903961D1 (de) 2002-12-19
IS5827A (is) 2001-01-26
RU2219179C2 (ru) 2003-12-20
US6555550B1 (en) 2003-04-29
JP2002523416A (ja) 2002-07-30
US6093724A (en) 2000-07-25
AR020199A1 (es) 2002-05-02
NO20010804L (no) 2001-04-11
YU13301A (sh) 2005-06-10
EP1112272A1 (en) 2001-07-04
HUP0103203A3 (en) 2002-10-28
IL141050A0 (en) 2002-02-10
NO20010804D0 (no) 2001-02-16
US6423842B1 (en) 2002-07-23
CN1312812A (zh) 2001-09-12
HUP0103203A2 (hu) 2002-01-28
AU750566B2 (en) 2002-07-25
ATE227724T1 (de) 2002-11-15
CA2340946A1 (en) 2000-03-02
PL346247A1 (en) 2002-01-28
AU5775899A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
ID26099A (id) Turunan amida dan antagonis nosiseptin
ID28291A (id) Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren
ID18003A (id) Antagonis muskarinik
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
EE03974B1 (et) Asendis 5 ja 6 modifitseeritud GnRH antagonistid
LV11460A (lv) Estrogenu agonisti un antagonisti
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID19623A (id) Antagonis reseptor vitronektin
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID26248A (id) Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin
EP1007026A4 (en) Integrin antagonists
FI970310L (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
ID30401A (id) Turunan-turunan indol dan penggunaannya sebagai antagonis mcp-1
ID17182A (id) Adrenergis b3 agonis pilihan
EP0986385A4 (en) GONADORELIN ANTAGONISTS
ID26848A (id) Koupling untuk gigi-gigi eksapator dan sejenisnya
EP0984779A4 (en) SOMATOSTATIN AGONISTS
ID24196A (id) Komposisi dan penggunaan
ID26599A (id) Turunan triazola dan imidazola
ATE227724T1 (de) Muscarinagonisten und antagonisten
ID22916A (id) Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
ID26223A (id) Antagonis reseptor vitronektin
ID28811A (id) Antagonis reseptor vitronektin
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina